Dawn Parsell Otto - Feb 28, 2022 Form 4 Insider Report for Tricida, Inc. (TCDA)

Role
EVP, Clinical Development
Signature
/s/ Geoffrey M. Parker, attorney-in-fact
Stock symbol
TCDA
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 03:52 PM
Previous filing
Jan 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCDA Employee Stock Option (right to buy) Award $0 +256K $0.00 256K Feb 28, 2022 Common Stock 256K $7.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on February 28, 2023, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date.